Predictors and determinants of albuminuria in people with prediabetes and diabetes based on smoking status: A cross-sectional study using the UK Biobank data

Bibliographic Details
Title: Predictors and determinants of albuminuria in people with prediabetes and diabetes based on smoking status: A cross-sectional study using the UK Biobank data
Authors: Debasish Kar, Aya El-Wazir, Gayathri Delanerolle, Anna Forbes, James P. Sheppard, Mintu Nath, Mark Joy, Nicholas Cole, J. Ranjit Arnold, Andrew Lee, Michael Feher, Melanie J. Davies, Kamlesh Khunti, Simon de Lusignan, Elizabeth Goyder
Source: EClinicalMedicine, Vol 51, Iss , Pp 101544- (2022)
Publisher Information: Elsevier, 2022.
Publication Year: 2022
Collection: LCC:Medicine (General)
Subject Terms: Albuminuria, Prediabetes, Type 2 diabetes, Smoking, Medicine (General), R5-920
More Details: Summary: Background: Smoking is attributed to both micro- and macrovascular complications at any stage of metabolic deregulation including prediabetes. Current global diabetes prevention programmes appear to be glucocentric, and do not fully acknowledge the ramifications of cardiorenal risk factors in smokers and ex-smokers. A more holistic approach is needed to prevent vascular complications in people with prediabetes and diabetes before and after quitting. Methods: A cross-sectional study was carried out on participants who agreed to take part in the UK Biobank dataset at the time of their first attendances between March 01, 2006, and December 31, 2010. Those who had their urinary albumin concentration (UAC) data available were included, and those who did not have this data, were excluded. A logistic regression model was fitted to explore the relationship between cardiorenal risk factors and albuminuria in people with prediabetes and diabetes, based on smoking status. Findings: A total of 502,490 participants were included in the UK Biobank dataset. Of them, 30.4% (n=152,896) had their UAC level recorded. Compared with non-smokers, the odds of albuminuria in smokers with prediabetes and diabetes were 1.21 (95% CI 1.05 – 1.39, p=0.009), and 1.26 (95% CI 1.10 – 1.44, p=0.001), respectively. The odds declined after quitting in both groups, but it was not statistically significant (p>0.05). Each unit increase in HbA1c was associated with equivalent increased odds of albuminuria in current and ex-smokers, OR 1.035 (95% CI 1.030 – 1.039, p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2589-5370
Relation: http://www.sciencedirect.com/science/article/pii/S2589537022002747; https://doaj.org/toc/2589-5370
DOI: 10.1016/j.eclinm.2022.101544
Access URL: https://doaj.org/article/9ad9f0f72d3744b9b838a663fc6b4182
Accession Number: edsdoj.9ad9f0f72d3744b9b838a663fc6b4182
Database: Directory of Open Access Journals
More Details
ISSN:25895370
DOI:10.1016/j.eclinm.2022.101544
Published in:EClinicalMedicine
Language:English